176 related articles for article (PubMed ID: 36615606)
1. Targeted Delivery of Sunitinib by MUC-1 Aptamer-Capped Magnetic Mesoporous Silica Nanoparticles.
Torabi M; Aghanejad A; Savadi P; Barzegari A; Omidi Y; Barar J
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615606
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer.
Siminzar P; Omidi Y; Golchin A; Aghanejad A; Barar J
J Drug Target; 2020 Jan; 28(1):92-101. PubMed ID: 31062625
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells.
Torabi M; Aghanejad A; Savadi P; Barzegari A; Omidi Y; Barar J
Bioimpacts; 2023; 13(3):255-267. PubMed ID: 37431477
[TBL] [Abstract][Full Text] [Related]
4. Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells.
Salve R; Kumar P; Chaudhari BP; Gajbhiye V
J Pharm Sci; 2023 May; 112(5):1450-1459. PubMed ID: 36669561
[TBL] [Abstract][Full Text] [Related]
5. Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells.
Aghanejad A; Babamiri H; Adibkia K; Barar J; Omidi Y
Bioimpacts; 2018; 8(2):117-127. PubMed ID: 29977833
[No Abstract] [Full Text] [Related]
6. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-based nanoparticles for cancer targeting.
Sá LT; Simmons S; Missailidis S; da Silva MI; Santos-Oliveira R
J Drug Target; 2013 May; 21(5):427-34. PubMed ID: 23350808
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica@chitosan@gold nanoparticles as "on/off" optical biosensor and pH-sensitive theranostic platform against cancer.
Esmaeili Y; Khavani M; Bigham A; Sanati A; Bidram E; Shariati L; Zarrabi A; Jolfaie NA; Rafienia M
Int J Biol Macromol; 2022 Mar; 202():241-255. PubMed ID: 35041881
[TBL] [Abstract][Full Text] [Related]
9. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
10. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents.
Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R
Pharm Dev Technol; 2019 Nov; 24(9):1063-1075. PubMed ID: 30654677
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in-vitro evaluation of mesoporous biogenic silica nanoparticles obtained from rice and wheat husk as a biocompatible carrier for anti-cancer drug delivery.
Porrang S; Rahemi N; Davaran S; Mahdavi M; Hassanzadeh B
Eur J Pharm Sci; 2021 Aug; 163():105866. PubMed ID: 33957220
[TBL] [Abstract][Full Text] [Related]
12. Functionalized magnetic mesoporous silica nanoparticles: fabrication, laccase adsorption performance and direct laccase capture from Trametes versicolor fermentation broth.
Wang F; Huang W; Guo C; Liu CZ
Bioresour Technol; 2012 Dec; 126():117-22. PubMed ID: 23073097
[TBL] [Abstract][Full Text] [Related]
13. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.
Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M
Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069
[TBL] [Abstract][Full Text] [Related]
14. Magnetic mesoporous silica nanoparticles: fabrication and their laccase immobilization performance.
Wang F; Guo C; Yang LR; Liu CZ
Bioresour Technol; 2010 Dec; 101(23):8931-5. PubMed ID: 20655206
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
17. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.
Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285
[TBL] [Abstract][Full Text] [Related]
18. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
19. Erianin-Loaded Photo-Responsive Dendrimer Mesoporous Silica Nanoparticles: Exploration of a Psoriasis Treatment Method.
Yu H; Liu Y; Zheng F; Chen W; Wei K
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234865
[TBL] [Abstract][Full Text] [Related]
20. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]